The global coagulation analyzer market size is estimated to stand at US$ 4.8 billion in 2024. The market is expected to exceed a valuation of US$ 9.2 billion by 2034, registering a moderate CAGR of 6.6%.
Coagulation Analyzer Market Overview:
Attributes | Details |
---|---|
Coagulation Analyzer Market Size (2024) | US$ 4.8 billion |
Coagulation Analyzer Market Forecasted Size (2034) | US$ 9.2 billion |
Projected Value CAGR (2024 to 2034) | 6.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Chronic Blood Disorders Steer Market Growth to New Heights! The primary factors driving the market expansion are the expanding elderly population and the increasing frequency of chronic blood disorders.
Increased Awareness Sparks a Surge in Coagulation Disorder Diagnosis and Testing! People are becoming increasingly aware of the consequences of coagulation disorder.
Government Backing Fuels Demand for Coagulation Disorder Solutions! The quality of healthcare services has improved due to government initiatives and increased healthcare spending. This has surged the demand for coagulation hemostasis tests and treatments, driving the market growth.
Innovative Coagulation Analyzers Spark a Technological Renaissance! Technological developments have resulted in the creation of progressively intricate coagulation analyzers.
The financial barriers hinder the growth of this market. In many developing and underdeveloped economies, the market faces challenges due to the high cost of fully automated analyzers. Limited resources in these economies make it difficult for healthcare facilities to invest in expensive automated coagulation analyzers. Moreover, the sluggish adoption of advanced hemostasis instruments like coagulation analyzers further hinders progress.
From 2019 to 2023, the coagulation analyzer industry showed promising growth, boasting a 9.8% CAGR. During this period, there has been a sharp increase in the number of coagulation screening tests conducted. Because of this, automated coagulation analyzers have become more efficient and effective. This has made it possible to create precise, high-throughput analyzers with little human measurement error.
Historical CAGR (2019 to 2023) | 9.8% |
---|---|
Forecasted CAGR (2024 to 2034) | 6.6% |
The market for coagulation analyzers is expected to exhibit a lower CAGR compared to the historical period. The use of modern technology has increased dramatically, such as polymerase chain reaction (PCR), flow cytometers, automated platelet function analyzers, and microarrays. When all of these technologies are combined, there is less pre- and post-analytical handling, which increases productivity and accuracy. Therefore, throughout the foreseeable period, manufacturers are likely to have more development prospects due to improvements in coagulation analyzers. This is also expected to have a highly positive impact on the global demand for coagulation analyzers.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The North America coagulation analyzer market stands out as a dominant force. The rising incidence of chronic blood diseases, the growing automation of labs, and the market participants' execution of strategic initiatives are the primary catalysts of the industry's growth. Europe is witnessing steady growth in demand for coagulation analyzers. This expansion is reinforced by sufficient clinics, hospitals, and health centers with medical professionals on hand who are qualified to offer efficient treatment. There is likely to be a historic progression in the Asia Pacific coagulation analyzer industry. Increasing investment in advanced healthcare technologies and growing demand for unconventional therapies support this growth.
Country | United States |
---|---|
Forecasted CAGR (2024 to 2034) | 6.7% |
Market Size by 2034 | US$ 1.6 billion |
Country | United Kingdom |
---|---|
Forecasted CAGR (2024 to 2034) | 7.7% |
Market Size by 2034 | US$ 366.1 million |
Country | China |
---|---|
Forecasted CAGR (2024 to 2034) | 6.9% |
Market Size by 2034 | US$ 1.4 million |
Country | Japan |
---|---|
Forecasted CAGR (2024 to 2034) | 7.8% |
Market Size by 2034 | US$ 1 billion |
Country | South Korea |
---|---|
Forecasted CAGR (2024 to 2034) | 8.8% |
Market Size by 2034 | US$ 558.7 million |
Demand for coagulation analyzers in the United States is set to rise with an anticipated CAGR of 6.7% through 2034. Key factors influencing the demand include:
The United Kingdom coagulation analyzer market is expected to surge at a CAGR of 7.7% through 2034. Top factors supporting the hemostasis analyzer market expansion in the country include:
The China coagulation analyzer market is forecasted to inflate at a CAGR of 6.9% through 2034. The main factors supporting the hemostasis/coagulation market growth are:
Sales of coagulation analyzers in Japan are estimated to record a CAGR of 7.8% through 2034. The primary factors bolstering the blood coagulation analyzer market size are:
The market in South Korea is likely to exhibit a CAGR of 8.8% through 2034. Reasons supporting the growth of the hemostasis-coagulation analysis market in the country include:
The semi-automated coagulation analyzer segment is likely to dominate the revenue share of coagulation analyzers through 2034, registering a CAGR of 6.5%. Similarly, the prothrombin time testing segment is expected to dominate by test type, with a projected CAGR of 6.3% through 2034.
Segment | Forecasted CAGR (2024 to 2034) |
---|---|
Semi-automated Coagulation Analyzer | 6.5% |
Prothrombin Time Testing | 6.3% |
The semi-automated coagulation analyzer segment is anticipated to lead the way, holding an impressive coagulation analyzer market share. The following factors contribute to its sales:
Prothrombin time testing takes the top spot in the market when it comes to blood testing for coagulation disorder, a trend substantiated by factors such as:
Coagulation analyzer market players employ diverse strategies to gain a competitive edge. Some concentrate on technology innovation, always bringing in cutting-edge innovations to satisfy changing demands in healthcare. Others place more emphasis on strategic alliances, working with significant stakeholders to improve market presence. Some place an intense focus on cost leadership by providing effective solutions at affordable prices.
Recent Developments
The coagulation analyzer industry is forecasted to be valued at US$ 4.8 billion in 2024.
The global coagulation analyzers market value is projected to surpass US$ 9.2 billion by 2034.
The CAGR of the coagulation analyzer industry is estimated to be around 6.6% through 2034.
The United States, China, and Japan are key consumers of coagulation analyzers as of 2024.
Abbott Laboratories, Siemens Healthcare GmbH, and Sysmex Corporation are coagulation analyzer industry leaders.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2024 to 2034 5.3.1. Semi-Automated Coagulation Analyzer 5.3.2. Automated Coagulation Analyzer 5.3.3. Manual Analyzers 5.3.4. Others 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Product Type, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Test Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2024 to 2034 6.3.1. Prothrombin Time Testing 6.3.2. Fibrinogen Testing 6.3.3. Activated Partial Thromboplastin Time Testing 6.3.4. D-dimer Testing 6.3.5. Platelet Function Testing 6.3.6. Anti-factor Xa Testing 6.3.7. Others 6.4. Y-o-Y Growth Trend Analysis By Test Type, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Test Type, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Technology 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2024 to 2034 7.3.1. Optical Technology 7.3.2. Mechanical Technology 7.3.3. Electrochemical Technology 7.3.4. Others 7.4. Y-o-Y Growth Trend Analysis By Technology, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Technology, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2019 to 2023 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2024 to 2034 8.3.1. Hospitals and Clinics 8.3.2. Diagnostic Centers 8.3.3. Others 8.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023 8.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. USA 10.2.1.2. Canada 10.2.2. By Product Type 10.2.3. By Test Type 10.2.4. By Technology 10.2.5. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Test Type 10.3.4. By Technology 10.3.5. By End User 10.4. Key Takeaways 11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Product Type 11.2.3. By Test Type 11.2.4. By Technology 11.2.5. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Test Type 11.3.4. By Technology 11.3.5. By End User 11.4. Key Takeaways 12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. UK 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Western Europe 12.2.2. By Product Type 12.2.3. By Test Type 12.2.4. By Technology 12.2.5. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Test Type 12.3.4. By Technology 12.3.5. By End User 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. Poland 13.2.1.2. Russia 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Product Type 13.2.3. By Test Type 13.2.4. By Technology 13.2.5. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Test Type 13.3.4. By Technology 13.3.5. By End User 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Product Type 14.2.3. By Test Type 14.2.4. By Technology 14.2.5. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Test Type 14.3.4. By Technology 14.3.5. By End User 14.4. Key Takeaways 15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Product Type 15.2.3. By Test Type 15.2.4. By Technology 15.2.5. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Test Type 15.3.4. By Technology 15.3.5. By End User 15.4. Key Takeaways 16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Product Type 16.2.3. By Test Type 16.2.4. By Technology 16.2.5. By End User 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Product Type 16.3.3. By Test Type 16.3.4. By Technology 16.3.5. By End User 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2023 17.1.2.1. By Product Type 17.1.2.2. By Test Type 17.1.2.3. By Technology 17.1.2.4. By End User 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2023 17.2.2.1. By Product Type 17.2.2.2. By Test Type 17.2.2.3. By Technology 17.2.2.4. By End User 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2023 17.3.2.1. By Product Type 17.3.2.2. By Test Type 17.3.2.3. By Technology 17.3.2.4. By End User 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2023 17.4.2.1. By Product Type 17.4.2.2. By Test Type 17.4.2.3. By Technology 17.4.2.4. By End User 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2023 17.5.2.1. By Product Type 17.5.2.2. By Test Type 17.5.2.3. By Technology 17.5.2.4. By End User 17.6. UK 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2023 17.6.2.1. By Product Type 17.6.2.2. By Test Type 17.6.2.3. By Technology 17.6.2.4. By End User 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2023 17.7.2.1. By Product Type 17.7.2.2. By Test Type 17.7.2.3. By Technology 17.7.2.4. By End User 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2023 17.8.2.1. By Product Type 17.8.2.2. By Test Type 17.8.2.3. By Technology 17.8.2.4. By End User 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2023 17.9.2.1. By Product Type 17.9.2.2. By Test Type 17.9.2.3. By Technology 17.9.2.4. By End User 17.10. Poland 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2023 17.10.2.1. By Product Type 17.10.2.2. By Test Type 17.10.2.3. By Technology 17.10.2.4. By End User 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2023 17.11.2.1. By Product Type 17.11.2.2. By Test Type 17.11.2.3. By Technology 17.11.2.4. By End User 17.12. Czech Republic 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2023 17.12.2.1. By Product Type 17.12.2.2. By Test Type 17.12.2.3. By Technology 17.12.2.4. By End User 17.13. Romania 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2023 17.13.2.1. By Product Type 17.13.2.2. By Test Type 17.13.2.3. By Technology 17.13.2.4. By End User 17.14. India 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2023 17.14.2.1. By Product Type 17.14.2.2. By Test Type 17.14.2.3. By Technology 17.14.2.4. By End User 17.15. Bangladesh 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2023 17.15.2.1. By Product Type 17.15.2.2. By Test Type 17.15.2.3. By Technology 17.15.2.4. By End User 17.16. Australia 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2023 17.16.2.1. By Product Type 17.16.2.2. By Test Type 17.16.2.3. By Technology 17.16.2.4. By End User 17.17. New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2023 17.17.2.1. By Product Type 17.17.2.2. By Test Type 17.17.2.3. By Technology 17.17.2.4. By End User 17.18. China 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2023 17.18.2.1. By Product Type 17.18.2.2. By Test Type 17.18.2.3. By Technology 17.18.2.4. By End User 17.19. Japan 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2023 17.19.2.1. By Product Type 17.19.2.2. By Test Type 17.19.2.3. By Technology 17.19.2.4. By End User 17.20. South Korea 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2023 17.20.2.1. By Product Type 17.20.2.2. By Test Type 17.20.2.3. By Technology 17.20.2.4. By End User 17.21. GCC Countries 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2023 17.21.2.1. By Product Type 17.21.2.2. By Test Type 17.21.2.3. By Technology 17.21.2.4. By End User 17.22. South Africa 17.22.1. Pricing Analysis 17.22.2. Market Share Analysis, 2023 17.22.2.1. By Product Type 17.22.2.2. By Test Type 17.22.2.3. By Technology 17.22.2.4. By End User 17.23. Israel 17.23.1. Pricing Analysis 17.23.2. Market Share Analysis, 2023 17.23.2.1. By Product Type 17.23.2.2. By Test Type 17.23.2.3. By Technology 17.23.2.4. By End User 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Product Type 18.3.3. By Test Type 18.3.4. By Technology 18.3.5. By End User 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Abbott Laboratories 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Danaher Corp 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Siemens Healthcare GmbH 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. Thermo Fisher Scientific Inc 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Sysmex Corporation 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Horiba Ltd. 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Nihon Kohden Corp 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. F. Hoffmann-La Roche Ltd 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Maccura Biotechnology Co Ltd 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. Bio Group Medical System SRL 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports